Change history
17 September 2021
"In this issue of" should be change to "In a recent issue of".
References
Barnes S, Haynes LW (1992) Low-voltage-activated calcium channels in human retinoblastoma cells. Brain Res 598:19–22
Bertolesi GE, Walia Da Silva R, Jollimore CA, Shi C, Barnes S, Kelly ME (2006) Ca(v)3.1 splice variant expression during neuronal differentiation of Y-79 retinoblastoma cells. Neuroscience 141:259–268
Carbone E, Lux HD (1987) Kinetics and selectivity of a low-voltage-activated calcium current in chick and rat sensory neurons. J Physiol 386:547–570
Dziegielewska B, Gray LS, Dziegielewski J (2014) T-type calcium channels blockers as new tools in cancer therapies. Pflügers Arch Eur J Physiol 466:801–810
El-Wakil MH, Teleb M, Abu-Serie MM, Huang S, Zamponi GW, Fahmy H (2021) Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide. Bioorg Chem 115:105262
Hirooka K, Bertolesi GE, Kelly ME, Denovan-Wright EM, Sun X, Hamid J, Zamponi GW, Juhasz AE, Haynes LW, Barnes S (2002) T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiation. J Neurophysiol 88:196–205
Howard MA, Dryja TP, Walton DS, Albert DM (1989) Identification and significance of multinucleate tumor cells in retinoblastoma. Arch Ophthalmol 107:1025–1030
Kim S, Guzman SJ, Jo DH, Cho CS, Kim JH (2021) Giant Y79 retinoblastoma cells contain functionally active T-type calcium channels. Pflügers Arch Eur J Physiol
Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ (2007) Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer 7:519–530
Nilius B, Carbone E (2014) Amazing T-type calcium channels: updating functional properties in health and disease. Pflügers Arch Eur J Physiol 466:623–626
Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu EW, Tralka TS, Wilcox JL (1974) Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 53:347–360
Roderick HL, Cook SJ (2008) Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer 8:361–375
Stenfelt S, Blixt MKE, All-Ericsson C, Hallböök F, Boije H (2017) Heterogeneity in retinoblastoma: a tale of molecules and models. Clin Transl Med 6:42
Zhang Y, Wang H, Qian Z, Feng B, Zhao X, Jiang X, Tao J (2014) Low-voltage-activated T-type Ca2+ channel inhibitors as new tools in the treatment of glioblastoma: the role of endostatin. Pflügers Arch Eur J Physiol 466:811–818
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is a commentary to the original article https://doi.org/10.1007/s00424-021–02612-4
Rights and permissions
About this article
Cite this article
Carbone, E. T-type calcium channels as therapeutic targets for treating “giant” retinoblastoma cancer cells. Pflugers Arch - Eur J Physiol 473, 1689–1690 (2021). https://doi.org/10.1007/s00424-021-02620-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-021-02620-4